Lessons from surgery after neoadjuvant chemoimmunotherapy for bulky, invasive N2 lung cancer: a case report. (PubMed, Gen Thorac Cardiovasc Surg Cases) - Sep 9, 2026 - "Radiographic response and pathologic complete response after chemoimmunotherapy do not necessarily indicate safe technical resectability in bulky, invasive N2 lung cancer. Multidisciplinary surgical planning should preserve caution when great-vessel invasion is suspected."
Journal • Fibrosis • Hematological Disorders • Hodgkin Lymphoma • Immunology • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|
|
Fumihiro Tanaka; Hidetaka Uramoto; Hiroki Matsumiya; Kanji Tanaka; Koji Kuroda; Masaru Takenaka; Masataka Mori; Takehiko Manabe; Teppei Hashimoto; Yasuhiro Fujita
|